Pfizer is recalling approximately 49,490 vials of Hospira-branded Lidocaine HCl and Sodium Bicarbonate injections because they may contain glass particles. The recall affects 1% Lidocaine, 2% Lidocaine, and 4.2% Sodium Bicarbonate packaged in glass ABBOJECT unit-of-use syringes distributed nationwide in the US and Puerto Rico. There have been no reports of injuries related to these products to date.
Injecting a product containing glass particles can cause localized irritation, inflammation, or allergic reactions. More seriously, the particles could travel through the bloodstream and cause blockages in blood vessels (embolism), which can be life-threatening if they reach the heart, lungs, or brain.
Distributed by Hospira Inc., Lake Forest, IL 60045
Distributed by Hospira Inc., Lake Forest, IL 60045
Distributed by Hospira Inc., Lake Forest, IL 60045
Image 1 “4.2% Sodium Bicarbonate Injection, USP”
Image 2 “1% Lidocaine HCl Injection, USP”
Image 3 “2% Lidocaine HCl Injection, USP”
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · FDA Press Release · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.